Dr. Steve Cutler was appointed Group President, Clinical Research Services in November 2011.

Steve has over 23 years’ experience within the pharmaceutical and CRO industry and joined ICON from Kendle where he held the position of Chief Executive Officer, having previously served as Kendle’s Chief Operating Officer. Prior to Kendle, Steve spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Steve held positions with Sandoz (now Novartis) in Australia and Europe. He holds a B.Sc. and a PhD from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).

Linda joined ICON as the Chief Operating Officer, ICON Clinical Research in August, 2010.  She has 30 years of pharmaceutical industry experience and is a globally recognized expert in the organization, resourcing and conducting of clinical trial programs.  Linda also holds a number of Advisory Board Member positions within the pharmaceutical industry.

Just prior to joining ICON, Linda served as Vice President, Global Clinical Operations at Glaxo Smith Kline (GSK) where she was responsible for Clinical Operations, Data Management, Training, Grants and Contracts, Alliance partnerships, SOP’s and Policies.  She joined GSK in 2001 where she developed the global operations clinical trial organization.

Linda started her career at Johnson and Johnson Pharmaceutical where she held a number of leadership positions from 1981 - 2001.

Linda is a registered pharmacist and a graduate of St. John’s University.
 

Jonathan joined ICON Clinical Research in April 2010 to lead the Strategic Programs group, with responsibility for strategic relationships and management of external alliances.  In December of 2010 he was appointed to the position of Executive Vice President of Strategic Development, with responsibility for Global Business Development, Proposals, Scientific Councils, Systems and Analysis, Strategic Sales, and Divisional Strategy.  Prior to joining ICON Clinical Research, he served as Chief Medical Officer and Senior Vice President of Medical Affairs at ICON Medical Imaging. From 2001–2007, he was Chief Medical Officer and Vice President of Medical Affairs at Point Biomedical, a development-stage biopharmaceutical company, with responsibility for medical affairs, clinical operations, data management and biostatistics.

Jonathan graduated with a distinction in his medical qualification at St Bartholomew's Hospital Medical College, London in 1989. He is certified in internal medicine, cardiology and several cardiac subspecialties. Jonathan has authored over 100 scientific publications and is a Fellow of seven prominent medical societies, including the American College of Cardiology, American College of Physicians, and the Royal College of Physicians in the UK. He currently maintains a Faculty appointment as an Associate Clinical Professor of Medicine at the University of California, San Francisco and serves as attending Cardiologist at the San Francisco Veterans’ Administration Medical Center.
 

Grace joined ICON in July 1993 and has worked in the QA department since November 1994. Grace has over 18 years’ pharmaceutical industry experience in the areas of clinical research and quality assurance. Her main responsibilities include implementing and maintaining an effective GCP Quality Assurance program and managing the US QA department.

Prior to joining ICON Clinical Research, Grace was a Medical Technologist at the Bryn Mawr Hospital for 7 years. In addition to her laboratory responsibilities, she was a member of the Total Quality Management Team and assisted in the Total Quality Improvement efforts of the laboratory that she worked in. Grace has an MSc in Clinical Microbiology from the Medical College of Pennsylvania and has been an active member of organizations such as SQA, SQA’s Clinical Specialty Section, MARSQA and MARSQA’s Computer Validation Committee and DIA. She earned the academic excellence award at the conclusion of her internship (Bryn Mawr Hospital medical technology program).
 

Sally joined ICON Clinical Research in 1993 in a Facilities Management role and as the organization grew, in 1996 Sally moved into a dedicated HR role with responsibility for UK then Europe and Asia Pacific.

During the past 17 year in ICON, Sally has grown and developed a team of HR professionals across Europe and Asia, which includes specialist teams in Recruitment and Compensation & Benefits. She has led a number of key initiatives which have enabled the division to continue to expand across the region. Allowing us to effectively manage, support and develop employees during a period of rapid growth, with additional technology and an adaptable approach to managing Human Resources. Sally has also been involved in a number of acquisitions across the ICON group.

Prior to joining ICON, Sally was in Facilities Management within the construction industry, during which she helped smaller organizations develop their facilities functions and managed a number of expansion projects. Sally holds a degree in Human Resource Management and is a qualified Mediator.
 

Dave joined ICON Clinical Research in November 1997 as Controller for the US and was most recently held the role of Vice President of Finance for the Americas . During the past 13 years with ICON, in addition to his finance and accounting responsibilities, he has led the Investigator Contracts and Grants Administration and the Contracts teams. He also handles the rate setting and pricing for the ICON Clinical Research division, as well as negotiating the pricing and terms for our strategic alliances.

Prior to joining ICON, Dave worked at the State Street Bank in Boston, KPMG in both Boston and Philadelphia and most recently at Alfa Laval, a Division of Tetra Pak. A Certified Public Accountant (CPA), he holds Bachelor’s degrees in Accounting and Computer Systems Management and has completed graduate coursework at Philadelphia University.
 

Ian joined ICON Clinical Research in May 2007 to lead the Clinical Support Services group, initially with responsibility for ISIS in Europe, Investigator Contracts Legal support, Planning and Resource Management, and Clinical Procurement. Through 2009 Ian led the ICON operational team in the transition and implementation of the Lilly ECOSI relationship in addition to continuing to lead ISIS in Europe. Prior to this, he served as Vice President of Clinical Operations for Phase II-IV at PRA with responsibility for Western Europe. From 2002–2005, he was Managing Director of Clinical Pharmacology for Covance, with responsibility for Clinical Operations, Business Development, Physicians, Data management and biostatistics based at their UK Clinical Pharmacology clinic. From 1999 -2001, Ian held the position of Commercial Director at the Covance Phase II-III business in a global role that supported Project Teams, Business Development, Contracts and Finance in Client relationships. Prior to this Ian managed a group that implemented Project Management and Tracking tools within Operations, and also operated as a Manager in Revenue recognition and Backlog management.

Ian graduated with an MBA, majoring in Project Management from Henley Business School in 2001.
 

Mike joined ICON in December 2002 having previously held a number of senior IT positions in the financial services industry with GE Capital and Woodchester Bank Ltd. Prior to this he worked as an IT Consultant and also as a Software Engineer. Michael has over 15 years’ experience in the IT Industry across many areas including Pharmaceuticals, Financial Services and Utilities. He holds an MSc in Information Technology Management and a Degree in Electronics

Dana has been with the company since March 1997, she initially joined as a Project Manager. Dana has held positions of increasing responsibility at ICON inclusive of Senior Vice President, US Clinical Operations for 5 years. Dana’s clinical research experience began as a CRA progressing to Project Manager during five years with ClinTrials Research. She began her career in health care as a neonatal intensive care nurse at Vanderbilt University prior to entering clinical research industry.

Simon has over 20 years’ experience in the pharmaceutical industry, most recently focusing on Asia-Pacific. Prior to joining ICON, Mr. Britton was Vice President, Clinical Development, Asia-Pacific at PPD, where he was responsible for developing, overseeing and executing the company’s development strategy within the region.

Mr Britton managed the International Clinical Operations division at GlaxoSmithKline from 2000 – 2007, a role which involved the management of clinical activities in 25 countries. Mr. Britton has also held senior business development and operational roles at INC Research and Parexel.

Malcolm Burgess joined ICON in December 2002 as Senior Vice President, Biometrics, and Data Management. In April 2006 Malcolm was appointed as Chief Operating Officer, US Operations. In addition he still maintains global leadership of the Biometrics and IVRS groups within ICON Clinical Research.

Prior to joining ICON Clinical Research, Dr Burgess held the position of Executive Director, Global Electronic Data Capture Logistics for Novartis. He has nearly 30 years experience within the Pharmaceutical sector having held various Research and Development positions within Novartis, Hoechst Marion Roussel and SmithKline Beecham.

Dr Burgess holds a BSc in Chemistry from University College, London and a Doctorate in Biochemistry and Physiology from Bath University, UK.

Kris Gustafson has been with ICON since 2000 in multiple roles.  In 2010 he was promoted to Senior VP Global Data and Technology Services having previously held the position as Global Head of Interactive Technologies and Lifecycle Sciences business unit. Prior to ICON, Kris was President and co-founder of Electronic Trial Management Technologies, a technology company specializing in IVR and IWR solutions for clinical trials, which was acquired by ICON in 2000. From 1995-1999 he served as Senior Director of Information Management at Applied Logic Associates. From 1990-1995 he worked as a Mechanical Engineer in the Nuclear sector.

Kris received his Bachelor of Science degree Mechanical Engineering from Washington State University in 1990.
 

Charles has over 20 years of experience in the pharmaceutical, biotechnology, and CRO industries. Currently, he is the Senior Vice President, Global Biostatistics and Programming at ICON Clinical Research. Charles started his career as a statistician supporting clinical research at Syntex (subsequently acquired by Roche), moved to Liposome Technology (renamed SEQUUS and subsequently acquired by Johnson & Johnson), before founding Pacific Research Associates (acquired by ICON in January 2000) with three other partners in 1995.

Dr. Du Mond has a PhD in Statistics from the University of Iowa.

Kevin joined ICON in November 2010 with more than 25 years of senior leadership experience in the global technology business.

As Senior Executive with Accenture, Kevin led Accenture’s European Shared Services and Global Procurement organizations. He also ran Business Processing Outsourcing (BPO) operations for a large European client. As Vice President and Managing Director with Oracle, Kevin led the development of a European Operations Centre encompassing Software Distribution, Development, Teleservices and e-Commerce. Most recently, as Chief Operating Officer with NewScope Group Holdings (a Swiss based Private Venture Capital company), Kevin was responsible for Business Development and Operations for a number of early stage technology/pharmaceutical companies.

Kevin holds an MBA from Santa Clara University and a First Class Honours degree in Engineering from Trinity College Dublin. Kevin also holds a BA in Maths from Trinity College Dublin.

Peter joined ICON in 2007 as VP Medical Affairs & Drug Safety Europe. In April 2010 he took over the global responsibility for all Medical and Safety Services.

Peter started his professional career at the MR Imaging Development Department of Siemens Medical Solutions. After further 8 years of basic and clinical epilepsy research at a Neurological University Hospital, he joined Pharmacia’s CNS franchise in 1995 and soon became Head Medical Affairs CNS for the Market Company Germany. In that role he was intensively involved in the launch of two new chemical entities for Parkinson’s and Major Depression and conducted several Phase I-IV studies in various CNS indications. In October 2000 he moved into the CRO business as Director for Medical Affairs at PRA, ultimately leading all Medical Monitors globally as VP Medical Affairs.  He authored multiple scientific articles and an eBook about Drug Development Methodology and is Head Lecturer for  Pharmaceutical Medicine at the University of Duisburg-Essen.

Peter is board certified in Neurology in Germany and in Pharmaceutical Medicine at the Swiss Medical Association.